Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Unilateral Arm Urticaria Presenting as a Paraneoplastic Manifestation of Metachronous Bilateral Breast Cancer.

Kasi PM, Hieken TJ, Haddad TC.

Case Rep Oncol. 2016 Jan 14;9(1):33-8. doi: 10.1159/000443661. eCollection 2016 Jan-Apr.

2.

Clonal evolution of AML on novel FMS-like tyrosine kinase-3 (FLT3) inhibitor therapy with evolving actionable targets.

Kasi PM, Litzow MR, Patnaik MM, Hashmi SK, Gangat N.

Leuk Res Rep. 2016 Jan 12;5:7-10. doi: 10.1016/j.lrr.2016.01.002. eCollection 2016.

3.

Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer.

Sinicrope FA, Okamoto K, Kasi PM, Kawakami H.

Clin Gastroenterol Hepatol. 2016 May;14(5):651-8. doi: 10.1016/j.cgh.2016.02.008. Epub 2016 Feb 9. Review.

PMID:
26872400
4.

Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma.

Zaidi AH, Kelly LA, Kreft RE, Barlek M, Omstead AN, Matsui D, Boyd NH, Gazarik KE, Heit MI, Nistico L, Kasi PM, Spirk TL, Byers B, Lloyd EJ, Landreneau RJ, Jobe BA.

BMC Cancer. 2016 Feb 2;16:52. doi: 10.1186/s12885-016-2093-8.

5.

Should Vital Signs Be Routinely Obtained Prior to Intravenous Chemotherapy? Results From a 2-Center Study.

Menon S, Foster NR, Looker S, Sorgatz K, Kasi PM, McWilliams RR, Jatoi A.

Cancer Control. 2015 Oct;22(4):515-9.

6.

Treatment of HIV/AIDS associated cancers with immunotherapy targeting PD-1/PD-L1 instead of chemotherapy.

Kasi PM, Block MS, Ansell SM.

Med Hypotheses. 2016 Jan;86:129-31. doi: 10.1016/j.mehy.2015.11.003. Epub 2015 Nov 5.

PMID:
26559886
7.

Transition of Care for Inpatient Hematology Patients Receiving Chemotherapy: Development of Hospital Discharge Huddle Process and Effects of Implementation.

Warsame R, Kasi PM, Villasboas-Bisneto JC, Gallenberg D, Wolf R, Ward J, Matt-Hensrud N, Grethen K, Colborn L, Zeldenrust S, Lacy MQ, Thompson CA.

J Oncol Pract. 2016 Jan;12(1):e88-94. doi: 10.1200/JOP.2015.005785. Epub 2015 Sep 15.

8.

Is obesity an advantage in patients with colorectal cancer?

Kasi PM, Zafar SY, Grothey A.

Expert Rev Gastroenterol Hepatol. 2015;9(11):1339-42. doi: 10.1586/17474124.2015.1089170. Epub 2015 Sep 14.

PMID:
26366838
9.

Chemotherapy in the Setting of Severe Liver Dysfunction in Patients with Metastatic Colorectal Cancer.

Kasi PM, Thanarajasingam G, Finnes HD, Villasboas Bisneto JC, Hubbard JM, Grothey A.

Case Rep Oncol Med. 2015;2015:420159. doi: 10.1155/2015/420159. Epub 2015 May 21.

10.

BRCA2-associated pancreatic cancer and current screening guidelines.

Kasi PM, Pedersen KS, McWilliams RR.

Cancer. 2015 Sep 1;121(17):3046. doi: 10.1002/cncr.29447. Epub 2015 May 27. No abstract available.

PMID:
26018189
11.

Nelarabine associated myotoxicity and rhabdomyolysis.

Haider M, Rizvi SA, Kasi PM.

Case Rep Hematol. 2015;2015:825670. doi: 10.1155/2015/825670. Epub 2015 Mar 18.

12.

MicroRNA signature characterizes primary tumors that metastasize in an esophageal adenocarcinoma rat model.

Zaidi AH, Saldin LT, Kelly LA, Bergal L, Londono R, Kosovec JE, Komatsu Y, Kasi PM, Shetty AA, Keane TJ, Thakkar SJ, Huleihel L, Landreneau RJ, Badylak SF, Jobe BA.

PLoS One. 2015 Mar 31;10(3):e0122375. doi: 10.1371/journal.pone.0122375. eCollection 2015.

13.

Waldenström macroglobulinemia.

Kasi PM, Ansell SM, Gertz MA.

Clin Adv Hematol Oncol. 2015 Jan;13(1):56-66. Review.

PMID:
25679974
14.

Selection of biologics for patients with metastatic colorectal cancer: the role of predictive markers.

Kasi PM, Hubbard JM, Grothey A.

Expert Rev Gastroenterol Hepatol. 2015 Mar;9(3):273-6. doi: 10.1586/17474124.2015.1001743. Epub 2015 Jan 12. Review.

PMID:
25579664
15.

Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma.

Zaidi AH, Gopalakrishnan V, Kasi PM, Zeng X, Malhotra U, Balasubramanian J, Visweswaran S, Sun M, Flint MS, Davison JM, Hood BL, Conrads TP, Bergman JJ, Bigbee WL, Jobe BA.

Cancer. 2014 Dec 15;120(24):3902-13. doi: 10.1002/cncr.28963. Epub 2014 Aug 5.

16.

Establishing magnetic resonance imaging as an accurate and reliable tool to diagnose and monitor esophageal cancer in a rat model.

Kosovec JE, Zaidi AH, Komatsu Y, Kasi PM, Cothron K, Thompson DV, Lynch E, Jobe BA.

PLoS One. 2014 Apr 4;9(4):e93694. doi: 10.1371/journal.pone.0093694. eCollection 2014.

17.

Safety of pegfilgrastim (neulasta) in patients with sickle cell trait/anemia.

Kasi PM, Patnaik MM, Peethambaram PP.

Case Rep Hematol. 2013;2013:146938. doi: 10.1155/2013/146938. Epub 2013 Dec 11.

18.

Prognostic value and targeted inhibition of survivin expression in esophageal adenocarcinoma and cancer-adjacent squamous epithelium.

Malhotra U, Zaidi AH, Kosovec JE, Kasi PM, Komatsu Y, Rotoloni CL, Davison JM, R C, Irvin, Hoppo T, Nason KS, Kelly LA, Gibson MK, Jobe BA.

PLoS One. 2013 Nov 4;8(11):e78343. doi: 10.1371/journal.pone.0078343. eCollection 2013.

19.

Clinical manifestations and diagnostic challenges in acute porphyrias.

Trier H, Krishnasamy VP, Kasi PM.

Case Rep Hematol. 2013;2013:628602. doi: 10.1155/2013/628602. Epub 2013 Feb 12.

20.

The use of intravenous neostigmine in palliation of severe ileus.

Kasi PM.

Case Rep Gastrointest Med. 2013;2013:796739. doi: 10.1155/2013/796739. Epub 2013 Feb 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk